WO2004069152A3 - Δ4,5 glycuronidase and uses thereof - Google Patents

Δ4,5 glycuronidase and uses thereof Download PDF

Info

Publication number
WO2004069152A3
WO2004069152A3 PCT/US2003/013938 US0313938W WO2004069152A3 WO 2004069152 A3 WO2004069152 A3 WO 2004069152A3 US 0313938 W US0313938 W US 0313938W WO 2004069152 A3 WO2004069152 A3 WO 2004069152A3
Authority
WO
WIPO (PCT)
Prior art keywords
glycuronidase
methods
relates
related compositions
compositions
Prior art date
Application number
PCT/US2003/013938
Other languages
French (fr)
Other versions
WO2004069152A2 (en
Inventor
James R Myette
Zachary Shriver
Ganesh Venkataraman
Ram Sasisekharan
Maitland W Mclean
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Priority to ES03815291T priority Critical patent/ES2421134T3/en
Priority to CA2484604A priority patent/CA2484604C/en
Priority to EP03815291.4A priority patent/EP1575534B1/en
Priority to AU2003303301A priority patent/AU2003303301B2/en
Priority to JP2004567979A priority patent/JP4416664B2/en
Publication of WO2004069152A2 publication Critical patent/WO2004069152A2/en
Publication of WO2004069152A3 publication Critical patent/WO2004069152A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01056—Glucuronosyl-disulfoglucosamine glucuronidase (3.2.1.56), i.e. glycuronidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01166—Heparanase (3.2.1.166)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The invention relates to Δ4,5 glycuronidase, related compositions, and methods of use thereof.
PCT/US2003/013938 2002-05-03 2003-05-05 Δ4,5 glycuronidase and uses thereof WO2004069152A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES03815291T ES2421134T3 (en) 2002-05-03 2003-05-05 delta 4,5 Glicuronidase and uses thereof
CA2484604A CA2484604C (en) 2002-05-03 2003-05-05 .delta. 4,5 glycuronidase and uses thereof
EP03815291.4A EP1575534B1 (en) 2002-05-03 2003-05-05 D4,5 glycuronidase and uses thereof
AU2003303301A AU2003303301B2 (en) 2002-05-03 2003-05-05 Delta4,5 glycuronidase and uses thereof
JP2004567979A JP4416664B2 (en) 2002-05-03 2003-05-05 Δ4,5 glycuronidase and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37748802P 2002-05-03 2002-05-03
US60/377,488 2002-05-03

Publications (2)

Publication Number Publication Date
WO2004069152A2 WO2004069152A2 (en) 2004-08-19
WO2004069152A3 true WO2004069152A3 (en) 2006-04-27

Family

ID=32850488

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/013938 WO2004069152A2 (en) 2002-05-03 2003-05-05 Δ4,5 glycuronidase and uses thereof

Country Status (7)

Country Link
US (7) US20050214276A9 (en)
EP (1) EP1575534B1 (en)
JP (2) JP4416664B2 (en)
AU (2) AU2003303301B2 (en)
CA (1) CA2484604C (en)
ES (1) ES2421134T3 (en)
WO (1) WO2004069152A2 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003527822A (en) * 1998-08-27 2003-09-24 マサチューセッツ インスティテュート オブ テクノロジー Rationally designed heparinases from heparinases I and II
CA2370539C (en) * 1999-04-23 2009-01-06 Massachusetts Institute Of Technology System and method for notating polymers
JP2003525946A (en) * 2000-03-08 2003-09-02 マサチューセッツ インスティテュート オブ テクノロジー Heparinase III and uses thereof
CA2422059C (en) 2000-09-12 2012-05-15 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
CA2423469A1 (en) 2000-10-18 2002-04-25 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
CA2484604C (en) * 2002-05-03 2011-08-02 Massachusetts Institute Of Technology .delta. 4,5 glycuronidase and uses thereof
CA2486456C (en) 2002-05-20 2012-07-17 Massachusetts Institute Of Technology Method for sequence determination using nmr
ATE481478T1 (en) * 2002-06-03 2010-10-15 Massachusetts Inst Technology RATIONALLY DESIGNED LYASES DERIVED FROM CHONDROITINASE B
JP4606712B2 (en) * 2003-01-08 2011-01-05 マサチューセッツ インスティテュート オブ テクノロジー 2-O sulfatase compositions and related methods
US7507570B2 (en) 2004-03-10 2009-03-24 Massachusetts Institute Of Technology Recombinant chondroitinase ABC I and uses thereof
US20100009928A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and taxanes and methods of use thereof
US20100009929A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
US20100028339A1 (en) * 2004-03-29 2010-02-04 Cheng Jin Q Compositions including triciribine and trastuzumab and methods of use thereof
CN1984663A (en) 2004-03-29 2007-06-20 南佛罗里达大学 Effective treatment of tumors and cancer with triciribine and related compounds
US20110008327A1 (en) 2004-03-29 2011-01-13 Cheng Jin Q Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
US20100173864A1 (en) 2004-03-29 2010-07-08 Cheng Jin Q Compositions including triciribine and one or more platinum compounds and methods of use thereof
US20060127950A1 (en) 2004-04-15 2006-06-15 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
WO2005111627A2 (en) * 2004-04-15 2005-11-24 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
CA2614068A1 (en) 2004-06-29 2006-08-24 Massachusetts Institute Of Technology Methods and compositions related to the modulation of intercellular junctions
WO2006083328A2 (en) * 2004-09-15 2006-08-10 Massachusetts Institute Of Technology Biologically active surfaces and methods of their use
US7767420B2 (en) 2005-11-03 2010-08-03 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
CN1870631B (en) * 2005-11-11 2010-04-14 华为技术有限公司 Gate control method of media gateway
EP2008096A2 (en) * 2006-04-03 2008-12-31 Massachusetts Institute of Technology Glycomic patterns for the detection of disease
AU2008205410B2 (en) 2007-01-05 2013-10-10 Massachusetts Institute Of Technology Compositions of and methods of using sulfatases from flavobacterium heparinum
WO2011140337A2 (en) * 2010-05-05 2011-11-10 New York University Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
KR101398764B1 (en) 2013-08-29 2014-05-27 강릉원주대학교산학협력단 Device for detecting analytes by moving the particle and method using the same
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
BR112018007525A2 (en) 2015-10-16 2018-10-30 Kansas State University Research Foundation porcine circovirus immunogenic compositions and methods of producing and using them
CN106018597B (en) * 2016-05-18 2018-12-21 山东大学 A kind of hydrophilic interaction chromatography multiple-reaction monitoring second order ms combination detection method of the basic component units of low molecular weight heparin
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016556A1 (en) 1995-10-30 1997-05-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase i
JP2003527822A (en) 1998-08-27 2003-09-24 マサチューセッツ インスティテュート オブ テクノロジー Rationally designed heparinases from heparinases I and II
US7056504B1 (en) * 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
IL127851A0 (en) 1998-12-30 1999-10-28 Applied Research Systems Inhibition of TNF activity
CA2370539C (en) * 1999-04-23 2009-01-06 Massachusetts Institute Of Technology System and method for notating polymers
AU782661B2 (en) 1999-06-30 2005-08-18 Hamilton Civic Hospitals Research Development, Inc. Heparin compositions that inhibit clot associated coagulation factors
JP2003525946A (en) * 2000-03-08 2003-09-02 マサチューセッツ インスティテュート オブ テクノロジー Heparinase III and uses thereof
DE10026699A1 (en) 2000-05-30 2001-12-06 Basf Ag Formulation based on heparin, glycosaminoglycan or heparinoid and use of the formulation and the formulation base
CA2422059C (en) * 2000-09-12 2012-05-15 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
CA2423469A1 (en) * 2000-10-18 2002-04-25 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
US20030008820A1 (en) * 2001-03-27 2003-01-09 Massachusetts Institute Of Technology Methods and products related to FGF dimerization
CA2484604C (en) 2002-05-03 2011-08-02 Massachusetts Institute Of Technology .delta. 4,5 glycuronidase and uses thereof
CA2486456C (en) * 2002-05-20 2012-07-17 Massachusetts Institute Of Technology Method for sequence determination using nmr
ATE481478T1 (en) * 2002-06-03 2010-10-15 Massachusetts Inst Technology RATIONALLY DESIGNED LYASES DERIVED FROM CHONDROITINASE B
JP4606712B2 (en) * 2003-01-08 2011-01-05 マサチューセッツ インスティテュート オブ テクノロジー 2-O sulfatase compositions and related methods
US7851223B2 (en) * 2004-02-27 2010-12-14 Roar Holding Llc Method to detect emphysema
US7507570B2 (en) * 2004-03-10 2009-03-24 Massachusetts Institute Of Technology Recombinant chondroitinase ABC I and uses thereof
WO2005111627A2 (en) 2004-04-15 2005-11-24 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
WO2005110438A2 (en) * 2004-04-15 2005-11-24 Massachusetts Institute Of Technology Methods and products related to the intracellular delivery of polysaccharides
US20060127950A1 (en) * 2004-04-15 2006-06-15 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
CA2614068A1 (en) 2004-06-29 2006-08-24 Massachusetts Institute Of Technology Methods and compositions related to the modulation of intercellular junctions
WO2006083328A2 (en) 2004-09-15 2006-08-10 Massachusetts Institute Of Technology Biologically active surfaces and methods of their use
JP2008525353A (en) * 2004-12-23 2008-07-17 ビーエーエスエフ ソシエタス・ヨーロピア Sterilization mixture
EP1841449A2 (en) * 2005-01-12 2007-10-10 The Massachusetts Institute Of Technology Methods and compositions related to modulating the extracellular stem cell environment
US20090155875A1 (en) 2005-02-16 2009-06-18 Massachusetts Institute Of Technology Methods to Enhance Carbon Monoxide Dehydrogenase Activity and Uses Thereof
US20090105463A1 (en) * 2005-03-29 2009-04-23 Massachusetts Institute Of Technology Compositions of and Methods of Using Oversulfated Glycosaminoglycans
WO2006105315A2 (en) 2005-03-29 2006-10-05 Massachusetts Institute Of Technology Compositions and methods for regulating inflammatory responses
US20060258610A1 (en) * 2005-05-12 2006-11-16 Isis Pharmaceuticals, Inc. Modulation of STAT 6 expression for the treatment of airway hyperresponsiveness
JP2007184847A (en) * 2006-01-10 2007-07-19 Nec Electronics Corp Clock and data recovery circuit and serdes circuit
EP2008096A2 (en) * 2006-04-03 2008-12-31 Massachusetts Institute of Technology Glycomic patterns for the detection of disease
AU2008205410B2 (en) 2007-01-05 2013-10-10 Massachusetts Institute Of Technology Compositions of and methods of using sulfatases from flavobacterium heparinum

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GU ET AL: "Purification, characterization and specificity of chondroitin lyases and glycuronidase from Flavobacterium heparinum.", BIOCHEM J., vol. 312, 1995, pages 569 - 577, XP002348573 *
LINKER ET AL: "The enzymatic degradation of heparin and heparin sulfate.", THE J BIOL CHEM., vol. 240, no. 10, pages 3724 - 3728, XP002998539 *
WARNICK ET AL, BIOCHEMISTRY., vol. 11, no. 4, 1972, pages 568 - 572, XP002998540 *
XU E TAL: "A genomic view of human-Bacteroides thetaiotamicron symbiosis.", SCIENCE., vol. 299, 2003, pages 2074 - 2076, XP002330198 *

Also Published As

Publication number Publication date
EP1575534B1 (en) 2013-04-10
US7695711B2 (en) 2010-04-13
ES2421134T3 (en) 2013-08-29
US7951560B2 (en) 2011-05-31
US20060177885A1 (en) 2006-08-10
AU2008243128A1 (en) 2008-11-27
US20100129868A1 (en) 2010-05-27
JP2009297029A (en) 2009-12-24
US20050214276A9 (en) 2005-09-29
US20060183891A1 (en) 2006-08-17
JP4416664B2 (en) 2010-02-17
CA2484604C (en) 2011-08-02
WO2004069152A2 (en) 2004-08-19
CA2484604A1 (en) 2004-08-19
AU2003303301A1 (en) 2004-08-30
US20040091471A1 (en) 2004-05-13
EP1575534A4 (en) 2008-05-21
JP2006504437A (en) 2006-02-09
US20060177911A1 (en) 2006-08-10
US20120045425A1 (en) 2012-02-23
AU2003303301B2 (en) 2008-08-07
US20060177910A1 (en) 2006-08-10
EP1575534A2 (en) 2005-09-21
AU2008243128B2 (en) 2011-11-24

Similar Documents

Publication Publication Date Title
WO2004069152A3 (en) Δ4,5 glycuronidase and uses thereof
WO2003000187A3 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
MXPA03008714A (en) Sequenced polymers and cosmetic compositions comprising the same.
WO2006069363A3 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
AU2001262475A1 (en) Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
EP2289492A3 (en) Naltrexone hydrochloride compositions
WO2003093269A3 (en) Substituted pyrazolo-pyrimidine-4-ones
CA2475302A1 (en) Controlled synthesis of ziprasidone and compositions thereof
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
WO2004001019A3 (en) Novel nanoparticles and use thereof
WO2003000188A3 (en) Novel quinazolines and uses thereof
WO2004084453A3 (en) METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES
ZA200501431B (en) 5-Aryltetrazole compounds, compositions thereof, and uses therefor.
WO2002072865A3 (en) Methods, kits and compositions of combination oligomers
WO2003000186A3 (en) Novel phenylamino-pyrimidines and uses thereof
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
WO2005009928A3 (en) Preparation and use of alkylating agents
WO2004087073A3 (en) Treatment of demyelinating conditions
WO2007022321A3 (en) Substituted indoles and use thereof
WO2003062443A3 (en) Novel substituted alkane compounds and uses thereof
WO2003000011A3 (en) Novel pyridopyrimidines and uses thereof
WO2004024077A3 (en) Novel composition and methods for the treatment of psoriasis
WO2002102324A3 (en) Anti-arthropod vector vaccines methods of selecting and uses thereof
SI1532141T1 (en) 2-PYRROLIDIN-2-YL- ?á1,3,4?å-OXADIAZOLE DERIVATIVES AND THE USE OF THE SAME AS ANTIDEPRESSANTS
WO2004026892A3 (en) Fragmentation of dna

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003303301

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2484604

Country of ref document: CA

Ref document number: 2004567979

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003815291

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003815291

Country of ref document: EP